SPRING HOUSE, PA-Johnson & Johnson Pharmaceutical Research & Development LLC has broken ground for a 150,000-sf research facility on the company’s existing 172-acre campus here. The new facility will serve as J&JPRD’s East Coast hub for discovery research and early clinical development.

The estimated construction cost is $181 million, according to a J&JPRD spokesman. The three-story structure “will be separate from, but connected to the main building on the campus,” he tells GlobeSt.com. It is scheduled to open in 2009.

The expansion will create 120 new jobs over the next three years and serve 680 existing employees. The J&JPRD spokesman says the company received a “blend of incentives from the state, totaling nearly $2.3 million.”

According to Gov. Ed Rendell’s office, the package included a grant of nearly $1.3 million through the state’s Infrastructure Development Program, a grant of up to $400,000 in opportunity grants, $125,000 in job training funds and $500,000 in job creation tax credits. The governor’s action team worked with the Montgomery County Industrial Development Corp to assemble the package.

“The new facility will provide our East Coast team with state of the art capabilities to accelerate drug discovery and early development programs,” says Joseph Scodari, Johnson & Johnson’s worldwide chairman of pharmaceuticals, in a statement. To date, more than 15 J&J products, including prescription drugs, have been discovered or developed on the campus.

Raritan, NJ-based J&JPRD is part of Johnson & Johnson. Other J&J early-stage drug-discovery research hubs are in La Jolla, CA and Beerse, Belgium.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2024 ALM Global, LLC. All Rights Reserved.